Prof. Dr. med. MPH, Emeritus Heiner Bucher

Ouchi D, García-Sangenís A, Moragas A, van der Velden AW, Verheij TJ, Butler CC, Bongard E, Coenen S, Cook J, Francis NA, Godycki-Cwirko M, Lundgren PT, Lionis C, Radzeviciene Jurgute R, Chlabicz S, De Sutter A, Bucher HC, Seifert B, Kovács B, et al. (2022). Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countries. Family Practice, 39(3), 398–405. https://doi.org/10.1093/fampra/cmab122

Delabays B, Cavassini M, Damas J, Beuret H, Calmy A, Hasse B, Bucher HC, Frischknecht M, Müller O, Méan M, Vollenweider P, Marques-Vidal P, & Vaucher J. (2022). Cardiovascular risk assessment in people living with HIV compared to the general population. European Journal of Preventive Cardiology, 29(4), 689–699. https://doi.org/10.1093/eurjpc/zwab201

Remera E, Mugwaneza P, Chammartin F., Mulindabigwi A, Musengimana G, Forrest JI, Mwanyumba F, Kondwani N, Condo JU, Riedel DJ, Mills EJ, Nsanzimana S, & Bucher HC. (2021). Towards elimination of mother‐to‐child transmission of HIV in Rwanda: a nested case‐control study of risk factors for transmission. BMC Pregnancy and Childbirth, 21(1). https://doi.org/10.1186/s12884-021-03806-5

Speich B, Chammartin F, Smith D, Stoeckle MP, Amico P, Eichenberger AL, Hasse B, Schuurmans MM, Müller T, Tamm M, Dickenmann M, Abela IA, Trkola A, Hirsch HH, Manuel O, Cavassini M, Hemkens LG, Briel M, Mueller NJ, et al. (2021). A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®. Trials, 22(1), 724. https://doi.org/10.1186/s13063-021-05664-0

Klingenberg R, Aghlmandi S, Räber L, Akhmedov A, Gencer B, Carballo D, Nanchen D, Bucher HC, Rodondi N, Mach F, Windecker S, Landmesser U, von Eckardstein A, Hamm CW, Lüscher TF, & Matter CM. (2021). Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes. Journal of the American Heart Association, 10(20), e020488. https://doi.org/10.1161/jaha.120.020488

Greenberg L, Ryom L, Neesgaard B, Wandeler G, Staub T, Gisinger M, Skoll M, Günthard HF, Scherrer A, Mussini C, Smith C, Johnson M, De Wit S, Necsoi C, Pradier C, Wit F, Lehmann C, d’Arminio Monforte A, Miró JM, et al. (2021). Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 73(7), e2323–e2333. https://doi.org/10.1093/cid/ciaa1878

Kappos EA, Schulz A, Regan MM, Moffa G, Harder Y, Ribi K, Potter S, Pusic AL, Fehr MK, Hemkens LG, Holzbach T, Farhadi J, Simonson C, Knauer M, Verstappen R, Bucher HC, Zwahlen D, Zimmermann F, Schwenkglenks M, et al. (2021). Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trial. BMJ Open, 11(9), e045239. https://doi.org/10.1136/bmjopen-2020-045239

Glinz D, Georg Hansen J, Trutmann C, Schaller B, Vogt J, Diermayr C, Marti A, Leitmeyer K, Doerig P, Zeller A, Welge-Luessen Lemcke A, & Bucher HC. (2021). Single-use device endoscopy for the diagnosis of acute bacterial rhinosinusitis in primary care: A pilot and feasibility study. Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 46(5), 1050–1056. https://doi.org/10.1111/coa.13785

Stuart B, Maund E, Wilcox C, Sridharan K, Sivaramakrishnan G, Regas C, Newell D, Soulsby I, Tang KF, Finlay AY, Bucher HC, Little P, Layton AM, & Santer M. (2021). Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis. The British Journal of Dermatology, 185(3), 512–525. https://doi.org/10.1111/bjd.20080

Venekamp RP, Hoogland J, van Smeden M, Rovers MM, De Sutter AI, Merenstein D, van Essen GA, Kaiser L, Liira H, Little P, Bucher HC, & Reitsma JB. (2021). Identifying adults with acute rhinosinusitis in primary care that benefit most from antibiotics: protocol of an individual patient data meta-analysis using multivariable risk prediction modelling. BMJ Open, 11(7), e047186. https://doi.org/10.1136/bmjopen-2020-047186

Chammartin F, Lodi S., Logan R., Ryom L, Mocroft A., Kirk O., d’Arminio Monforte A, Reiss P., Phillips A., El-Sadr W, Hatleberg CI, Pradier C, Bonnet F, Law M, De Wit S, Sabin C., Lundgren J.D., Bucher HC, D:A:D Study Group, et al. (2021). Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study. Annals of Internal Medicine, 174(6), 768–776. https://doi.org/10.7326/m20-5226

Kaech M, Deutschmann E., Moffa G., Haak F., Bucher HC, Kettelhack C, & von Strauss Und Torney M. (2021). Influence of the introduction of caseload requirements on indication for visceral cancer surgery in Switzerland. European Journal of Surgical Oncology, 47(6), 1324–1331. https://doi.org/10.1016/j.ejso.2021.04.006

Stuart B, Hounkpatin H, Becque T, Yao G, Zhu S, Alonso-Coello P, Altiner A, Arroll B, Böhning D, Bostock J, Bucher HC, Chao J, de la Poza M, Francis N, Gillespie D, Hay AD, Kenealy T, Löffler C, McCormick DP, et al. (2021). Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ (Clinical Research Ed.), 373, n808. https://doi.org/10.1136/bmj.n808

The RESPOND study group. (2021). The interrelationship of smoking, CD4+cell count, viral load and cancer in persons living with HIV. Aids, 35(5), 747–757. https://doi.org/10.1097/QAD.0000000000002791

Glinz D, Mc Cord KA, Moffa G, Aghlmandi S, Saccilotto R, Zeller A, Widmer AF, Bielicki J, Kronenberg A, & Bucher HC. (2021). Antibiotic prescription monitoring and feedback in primary care in Switzerland: Design and rationale of a nationwide pragmatic randomized controlled trial. Contemporary Clinical Trials Communications, 21, 100712. https://doi.org/10.1016/j.conctc.2021.100712

Klingenberg R, Aghlmandi S, Gencer B, Nanchen D, Räber L, Carballo D, Carballo S, Stähli BE, Landmesser U, Rodondi N, Mach F, Windecker S, Bucher HC, von Eckardstein A, Lüscher TF, & Matter CM. (2021). Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events. Atherosclerosis, 320, 31–37. https://doi.org/10.1016/j.atherosclerosis.2021.01.012

Audigé, Laurent, Bucher, Heiner C.C., Aghlmandi, Soheila, Stojanov, Thomas, Schwappach, David, Hunziker, Sabina, Candrian, Christian, Cunningham, Gregory, Durchholz, Holger, Eid, Karim, Flury, Matthias, Jost, Bernhard, Lädermann, Alexandre, Moor, Beat Kaspar, Moroder, Philipp, Rosso, Claudio, Schär, Michael, Scheibel, Markus, Spormann, Christophe, et al. (2021). Swiss-wide multicentre evaluation and prediction of core outcomes in arthroscopic rotator cuff repair: Protocol for the ARCR_Pred cohort study. BMJ Open, 11. https://doi.org/10.1136/bmjopen-2020-045702

Zens Y, Barth M, Bucher HC, Dreck K, Felsch M, Groß W, Jaschinski T, Kölsch H, Kromp M, Overesch I, Sauerland S, & Gregor S. (2020). Negative pressure wound therapy in patients with wounds healing by secondary intention: a systematic review and meta-analysis of randomised controlled trials. Systematic Reviews, 9(1), 238. https://doi.org/10.1186/s13643-020-01476-6

Kronlage C, Hardmeier M, Bally S, Scholz MC, Bucher HC, Müller OK, Winterhalder C., Mongiat M, Müller J, Polymeris A, Weber M, Lausberg C, Kassi E, Kuhle J, Kappos L, Hermann W, Bernsmeier C, & Yaldizli Ö. (2020). Muscle stiffness, gait instability, and liver cirrhosis in Wilson’s disease. Lancet (London, England), 396(10256), 990. https://doi.org/10.1016/s0140-6736(20)31963-2

d’Arminio Monforte A, Bonnet F, Bucher HC, Pourcher V, Pantazis N, Pelchen-Matthews A, Touloumi G, & Wolf E. (2020). What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohorts. HIV Medicine, 21 Suppl 2, 3–16. https://doi.org/10.1111/hiv.12935

Gryaznov D, Chammartin F., Stoeckle M., Anagnostopoulos A., Braun DL, Furrer H., Boillat-Blanco N, Bernasconi E., Schmid P, Nordmann A., & Bucher HC. (2020). Smartphone App and Carbon Monoxide Self-Monitoring Support for Smoking Cessation: A Randomized Controlled Trial Nested into the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 85(1), E8–E11. https://doi.org/10.1097/qai.0000000000002396

Dell-Kuster S, Gomes NV, Gawria L, Aghlmandi S, Aduse-Poku M, Bissett I, Blanc C, Brandt C, Ten Broek RB, Bruppacher HR, Clancy C, Delrio P, Espin E, Galanos-Demiris K, Gecim IE, Ghaffari S, Gié O, Goebel B, Hahnloser D, et al. (2020). Prospective validation of classification of intraoperative adverse events (ClassIntra): international, multicentre cohort study. BMJ (Clinical Research Ed.), 370, m2917. https://doi.org/10.1136/bmj.m2917

Nsanzimana S, Mills EJ, Harari O, Mugwaneza P, Karita E, Uwizihiwe JP, Park JJ, Dron L, Condo J, Bucher H, & Thorlund K. (2020). Prevalence and incidence of HIV among female sex workers and their clients: modelling the potential effects of intervention in Rwanda. BMJ Global Health, 5(8). https://doi.org/10.1136/bmjgh-2020-002300

Weber WP, Morrow M, Boniface J, Pusic A, Montagna G, Kappos EA, Ritter M, Haug M, Kurzeder C, Saccilotto R, Schulz A., Benson J, Fitzal F, Matrai Z, Shaw J, Peeters MV, Potter S, Heil J, Oncoplastic Breast Consortium., & Oncoplastic Breast Consortium. (2020). Knowledge gaps in oncoplastic breast surgery. The Lancet Oncology, 21(8), e375–e385. https://doi.org/10.1016/s1470-2045(20)30084-x

Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, Cook J, Francis NA, Lewis RJ, Godycki-Cwirko M, Llor C, Chlabicz S, Lionis C, Seifert B, Sundvall PD, Colliers A, Aabenhus R, Bjerrum L, Jonassen Harbin N, et al. (2020). Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Lancet (London, England), 395(10217), 42–52. https://doi.org/10.1016/s0140-6736(19)32982-4

von Strauss und Torney, Marco, Moffa, Giusi, Kaech, Max, Haak, Fabian, Riss, Stefan, Deutschmann, Elisabeth, Bucher, Heiner C., Kettelhack, Christoph, & Paterson, Hugh M. (2020). Risk of Emergency Surgery or Death After Initial Nonoperative Management of Complicated Diverticulitis in Scotland and Switzerland. JAMA Surgery, 155(7), 600–606. https://doi.org/10.1001/jamasurg.2020.0757

Lodi S, Günthard HF, Gill J, Phillips AN, Dunn D, Vu Q, Siemieniuk R, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Reiss P, van Sighem A, Boender TS, Porter K, Gilson R, Paraskevis D, Simeon M, et al. (2019). Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals. Journal of Acquired Immune Deficiency Syndromes (1999), 82(3), 314–320. https://doi.org/10.1097/qai.0000000000002135

Surial B, Cavassini M, Calmy A, Fehr J, Stöckle M, Bernasconi E, Roth B, Fux CA, Kovari H, Furrer H, Rauch A, Wandeler G, & Swiss HIV Cohort Study. (2019). Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort. BMC Infectious Diseases, 19(1), 834. https://doi.org/10.1186/s12879-019-4454-9

Andreas C., Jaled C., Johannes T H., Lukas E., Laura W., Andri R., Hansjakob F., Andreas M., Uyen H.-D., Spyridon A., Nicolas J M., Matthias C., Matteo M., Christian V.D., Thomas F., Xavier M., Catherine B.-A., Amico P., Aubert J.-D., et al. (2019). Imaging patterns of pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients - A multicentre study. Swiss Medical Weekly, 149(39-40). https://doi.org/10.4414/smw.2019.20130

Barcelo C., Aouri M., Courlet P., Guidi M., Braun D.L., Gunthard H.F., Piso R.J., Cavassini M., Buclin T., Decosterd L.A., Csajka C., Anagnostopoulos A., Battegay M., Bernasconi E., Boni J., Braun D.L., Bucher H.C., Calmy A., Cavassini M., et al. (2019). Population pharmacokinetics of dolutegravir: Influence of drug-drug interactions in a real-life setting. Journal of Antimicrobial Chemotherapy, 74(9), 2690–2697. https://doi.org/10.1093/jac/dkz217

Kernen P, Steveling-Klein EH, Saccilotto RT, Raatz H, Briel M, Koller MT, Westwood M, Bucher HC, Miedinger D, & Leuppi JD. (2019). The sensitivity and specificity of the mannitol bronchial challenge test to identify asthma in different populations: a systematic review. Swiss Medical Weekly, 149, w20100. https://doi.org/10.4414/smw.2019.20100

Lodi S, Phillips A, Lundgren J, Logan R, Sharma S, Cole SR, Babiker A, Law M, Chu H, Byrne D, Horban A, Sterne JAC, Porter K, Sabin C, Costagliola D, Abgrall S, Gill J, Touloumi G, Pacheco AG, et al. (2019). Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples. American Journal of Epidemiology, 188(8), 1569–1577. https://doi.org/10.1093/aje/kwz100

Hachfeld, A., Darling, K., Calmy, A., Ledergerber, B., Weber, R., Battegay, M., Wissel, K., Di Benedetto, C., Fux, C.A., Tarr, P.E., Kouyos, R., Ruggia, L.S., Furrer, H.J., Wandeler, G., Aubert, V., Battegay, M., Bernasconi, E., Böni, J., Braun, D.L., et al. (2019). Why do sub-Saharan Africans present late for HIV care in Switzerland? HIV Medicine, 20(6), 418–423. https://doi.org/10.1111/hiv.12727

Glinz D, Gloy VL, Monsch AU, Kressig RW, Patel C, McCord KA, Ademi Z, Tomonaga Y, Schwenkglenks M, Bucher HC, & Raatz H. (2019). Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer’s disease: A meta-analysis. Swiss Medical Weekly, 149(25-26), w20093. https://doi.org/10.4414/smw.2019.20093

Carlisle L.A., Turk T, Kusejko K, Metzner KJ, Leemann C., Schenkel C.D., Bachmann N, Posada S., Beerenwinkel N., Böni J, Yerly S, Klimkait T, Perreau M, Braun DL, Rauch A, Calmy A, Cavassini M., Battegay M, Vernazza P., et al. (2019). Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection. Journal of Infectious Diseases, 220(2), 254–265. https://doi.org/10.1093/infdis/jiz094

Kusejko K., Bachmann N., Chaudron S.E., Nguyen H., Braun D.L., Hampel B., Battegay M, Bernasconi E, Calmy A., Cavassini M, Hoffmann M, Boni J., Yerly S., Klimkait T, Perreau M., Rauch A., Gunthard H.F., Kouyos R.D., Swiss HIV Cohort Study., et al. (2019). A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 with Coinfections, Noncommunicable Diseases, and Opportunistic Diseases. Journal of Infectious Diseases, 220(2), 244–253. https://doi.org/10.1093/infdis/jiz093

Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, et al. (2019). Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals. Statistics in Medicine, 38(13), 2428–2446. https://doi.org/10.1002/sim.8120

Roethlisberger M, Achermann R, Bawarjan S, Stienen MN, Fung C, D’Alonzo D, Maldaner N, Ferrari A, Corniola MV, Schöni D, Goldberg J, Valsecchi D, Robert T, Maduri R, Seule MA, Burkhardt JK, Marbacher S, Bijlenga P, Blackham KA, et al. (2019). Impact of Aneurysm Multiplicity on Treatment and Outcome After Aneurysmal Subarachnoid Hemorrhage. Neurosurgery, 84(6), E334–E344. https://doi.org/10.1093/neuros/nyy331

Leon-Reyes S., Schafer J., Fruh M., Schwenkglenks M., Reich O., Schmidlin K., Staehelin C., Battegay M., Cavassini M., Hasse B., Bernasconi E., Calmy A., Hoffmann M., Schoeni-Affolter F., Zhao H., & Bucher H.C. (2019). Cost estimates for Human Immunodeficiency Virus (HIV) care and patient characteristics for health resource use from linkage of claims data with the swiss HIV cohort study. Clinical Infectious Diseases, 68(5), 827–833. https://doi.org/10.1093/cid/ciy564

Braun DL, Hampel B, Martin E, Kouyos R, Kusejko K, Grube C, Flepp M, Stöckle M, Conen A, Béguelin C, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS, & Swiss HIV Cohort Study. (2019). High number of potential transmitters revealed in a population-based systematic hepatitis C Virus RNA screening among human immunodeficiency virus-infected men who have sex with men. Clinical Infectious Diseases, 68(4), 561–568. https://doi.org/10.1093/cid/ciy545

Stuart B, Hounkpatin H, Becque T, Yao G, Zhu S, Alonso-Coello P, Altiner A, Arroll B, Böhning D, Bostock J, Bucher HCC, de la Poza M, Francis NA, Gillespie D, Hay AD, Kenealy T, Löffler C, Mas-Dalmau G, Muñoz L, et al. (2019). Delayed antibiotic prescribing for respiratory tract infections: protocol of an individual patient data meta-analysis. BMJ Open, 9(1), e026925. https://doi.org/10.1136/bmjopen-2018-026925

Bachmann, Nadine, von Siebenthal, Chantal, Vongrad, Valentina, Turk, Teja, Neumann, Kathrin, Beerenwinkel, Niko, Bogojeska, Jasmina, Fellay, Jaques, Roth, Volker, Kok, Yik Lim, Thorball, Christian W., Borghesi, Alessandro, Parbhoo, Sonali, Wieser, Mario, Böni, Jürg, Perreau, Matthieu, Klimkait, Thomas, Yerly, Sabine, Battegay, Manuel, et al. (2019). Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART. Nature Communications, 10. https://doi.org/10.1038/s41467-019-10884-9

Courlet, Perrine, Livio, Françoise, Guidi, Monia, Cavassini, Matthias, Battegay, Manuel, Stoeckle, Marcel, Buclin, Thierry, Saldanha, Susana Alves, Csajka, Chantal, Marzolini, C., Decosterd, Laurent, Anagnostopoulos, A., Battegay, M., Bernasconi, E., Böni, J., Braun, D.L., Bucher, H.C., Calmy, A., Cavassini, M., et al. (2019). Polypharmacy, drug–drug interactions, and inappropriate drugs: New challenges in the aging population with HIV. Open Forum Infectious Diseases, 6. https://doi.org/10.1093/ofid/ofz531

Leon-Reyes, Selene, Schäfer, Juliane, Früh, Mathias, Schwenkglenks, Matthias, Reich, Oliver, Schmidlin, Kurt, Staehelin, Cornelia, Battegay, Manuel, Cavassini, Matthias, Hasse, Barbara, Bernasconi, Enos, Calmy, Alexandra, Hoffmann, Matthias, Schoeni-Affolter, Franziska, Zhao, Hongwei, & Bucher, Heiner C. (2019). Cost estimates for HIV care and patient characteristics for health resource utilisation from linkage of claims data with the Swiss HIV Cohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 68, 827–833. https://doi.org/10.1093/cid/ciy564

Young J, Scherrer AU, Calmy A, Tarr PE, Bernasconi E, Cavassini M, Hachfeld A, Vernazza P, Günthard HF, Bucher HC, & Swiss HIV Cohort Study. (2019). The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study. Antiviral Therapy, 24(5), 343–353. https://doi.org/10.3851/imp3310

Vach W, Saxer F, Holsgaard-Larsen A, Overgaard S, Farin-Glattacker E, Bless N, Bucher HC, & Jakob M. (2018). Rationale and methods of an observational study to support the design of a nationwide surgical registry: the MIDAS study. Swiss Medical Weekly, 148, w14680. https://doi.org/10.4414/smw.2018.14680

Zumofen DW, Zumofen DW, Roethlisberger M, Achermann R, Bawarjan S, Stienen MN, Fung C, D’Alonzo D, Maldaner N, Ferrari A, Corniola MV, Schoeni D, Goldberg J, Valsecchi D, Robert T, Maduri R, Seule M, Burkhardt JK, Marbacher S, et al. (2018). Factors associated with clinical and radiological status on admission in patients with aneurysmal subarachnoid hemorrhage. Neurosurgical Review, 41(4), 1059–1069. https://doi.org/10.1007/s10143-018-0952-2

Leu S, Boulay JL, Thommen S, Bucher HC, Stippich C, Mariani L, & Bink A. (2018). Preoperative Two-Dimensional Size of Glioblastoma is Associated with Patient Survival. World Neurosurgery, 115, e448–e463. https://doi.org/10.1016/j.wneu.2018.04.067

Beguelin C., Suter A., Bernasconi E., Fehr J, Kovari H, Bucher HC, Stoeckle M., Cavassini M., Rougemont M., Schmid P., Wandeler G, Rauch A, Swiss HIV Cohort Study, Battegay M., Boni J., Braun D.L., Calmy A., Ciuffi A., Dollenmaier G., et al. (2018). Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study. Liver International, 38(3), 424–431. https://doi.org/10.1111/liv.13528

Stirrup OT, Copas AJ, Phillips AN, Gill MJ, Geskus RB, Touloumi G, Young J, Bucher HC, Babiker AG, & CASCADE Collaboration in EuroCoord. (2018). Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion. HIV medicine, 19(3), 184–194. https://doi.org/10.1111/hiv.12567

Young, J., Smith, C., Teira, R., Reiss, P., Jarrin Vera, I., Crane, H., Miro, J. M., Monforte, A. D’Arminio, Saag, M., Zangerle, R., & Bucher, H. C. (2018). Antiretroviral pill count and clinical outcomes in treatment-naive patients with HIV infection. HIV MEDICINE, 19, 132–142. https://doi.org/10.1111/hiv.12562

Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Annane D, et al. (2018). Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. The Lancet. Infectious diseases, 18(1), 95–107. https://doi.org/10.1016/s1473-3099(17)30592-3

Sendi, P., Oppliger, N., Chakroun, F., Marinello, C.P., Bucher, H.C., & Bornstein, M.M. (2018). Health State Utilities in Edentulous Patients: A Time Trade-off Approach. JDR Clinical and Translational Research, 3, 346–352. https://doi.org/10.1177/2380084418789056

Glinz D, Leon Reyes S, Saccilotto R, Widmer AF, Zeller A, Bucher HC, & Hemkens LG. (2017). Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey. The Journal of antimicrobial chemotherapy, 72(11), 3205–3212. https://doi.org/10.1093/jac/dkx278

Lodi, Sara, Costagliola, Dominique, Sabin, Caroline, del Amo, Julia, Logan, Roger, Abgrall, Sophie, Reiss, Peter, van Sighem, Ard, Jose, Sophie, Blanco, Jose-Ramon, Hernando, Victoria, Bucher, Heiner C., Kovari, Helen, Segura, Ferran, Ambrosioni, Juan, Gogos, Charalambos A., Pantazis, Nikos, Dabis, Francois, Vandenhende, Marie-Anne, et al. (2017). Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older. 76, 311–318.

Blaser, Nello, Bertisch, Barbara, Calmy, Alexandra, Calmy A., Estill, Janne, Keiser, Olivia, Egger, Matthias, Keiser O., Bucher, Heiner C., Aubert V., Battegay M., Bernasconi E., Boni J., Braun D.L., Bucher H.C., Calmy A., Cavassini M., Ciuffi A., Dollenmaier G., et al. (2017). Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM. Aids, 31(13), 1859–1866. https://doi.org/10.1097/qad.0000000000001546

Mechera R, Dell-Kuster S, von Strauss Und Torney M, Langer I, Furrer M, Bucher HC, & Rosenthal R. (2017). Tutorial Assistance for Board Certification in Surgery: Frequency, Associated Time and Cost. World journal of surgery, 41(8), 1950–1960. https://doi.org/10.1007/s00268-017-3996-5

Odermatt J, Meili M, Hersberger L, Bolliger R, Christ-Crain M, Briel M, Bucher HC, Mueller B, & Schuetz P. (2017). Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study. BMC cardiovascular disorders, 17(1), 178. https://doi.org/10.1186/s12872-017-0605-3

Negoescu, Diana M., Zhang, Zhenhuan, Bucher, Heiner C., & Bendavid, Eran. (2017). Differentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic Analysis. CLINICAL INFECTIOUS DISEASES, 64, 1724–1730. https://doi.org/10.1093/cid/cix177

Caniglia, Ellen C., Cain, Lauren E., Sabin, Caroline A., Robins, James M., Logan, Roger, Abgrall, Sophie, Mugavero, Michael J., Hernandez-Diaz, Sonia, Meyer, Laurence, Seng, Remonie, Drozd, Daniel R., Seage, George R., III, Bonnet, Fabrice, Dabis, Francois, Moore, Richard D., Reiss, Peter, van Sighem, Ard, Mathews, William C., del Amo, Julia, et al. (2017). Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. LANCET HIV, 4, E251–E259. https://doi.org/10.1016/s2352-3018(17)30043-7

Dell-Kuster S, Hoesli I, Lapaire O, Seeberger E, Steiner LA, Bucher HC, & Girard T. (2017). Efficacy and safety of carbetocin given as an intravenous bolus compared with short infusion for Caesarean section - double-blind, double-dummy, randomized controlled non-inferiority trial. British Journal of Anaesthesia, 118(5), 772–780. https://doi.org/10.1093/bja/aex034

Rosenthal R, Bucher HC, & Dwan K. (2017). The Use of Systematic Reviews When Designing and Reporting Surgical Trials. (Patent No. 4). 265(4), Article 4. https://doi.org/10.1097/sla.0000000000001092

Monge, S., Jarrin, I., Pantazis, N., Mocroft, A., Sabin, C. A., Touloumi, G., van Sighem, A., Abgrall, S., Dray-Spira, R., Spire, B., Castagna, A., Mussini, C., Zangerle, R., Hessamfar, M., Anderson, J., Hamouda, O., Ehren, K., Obel, N., Kirk, O., et al. (2017). Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe. AIDS, 31, 835–846. https://doi.org/10.1097/qad.0000000000001411

Fidler, Sarah, Olson, Ashley D., Bucher, Heiner C., Fox, Julie, Thornhill, John, Morrison, Charles, Muga, Roberto, Phillips, Andrew, Frater, John, & Porter, Kholoud. (2017). Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 74, 126–133.

Hemkens L.G., Saccilotto R., Reyes S.L., Glinz D., Zumbrunn T., Grolimund O., Gloy V., Raatz H., Widmer A., Zeller A., & Bucher H.C. (2017). Personalized prescription feedback using routinely collected data to reduce antibiotic use in primary care a randomized clinical trial. JAMA Internal Medicine, 177(2), 176–183. https://doi.org/10.1001/jamainternmed.2016.8040

Wang, Qing, De Luca, Andrea, Smith, Colette, Zangerle, Robert, Sambatakou, Helen, Bonnet, Fabrice, Smit, Colette, Schommers, Philipp, Thornton, Alicia, Berenguer, Juan, Peters, Lars, Spagnuolo, Vincenzo, Ammassari, Adriana, Antinori, Andrea, Roldan, Eugenia Quiros, Mussini, Cristina, Miro, Jose M., Konopnicki, Deborah, Fehr, Jan, et al. (2017). Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients. ANNALS OF INTERNAL MEDICINE, 166, 9–+. https://doi.org/10.7326/m16-0240

Ewald, Hannah, Santini-Oliveira, Marilia, Bühler, Julian-Emanuel, Vuichard, Danielle, Schandelmaier, Stefan, Stöckle, Marcel, Briel, Matthias, Bucher, Heiner C., & Hemkens, Lars G. (2017). Comparative effectiveness of tenofovir in HIV-infected treatment-experienced patients: systematic review and meta-analysis. HIV clinical trials, 18(1), 17–27. https://doi.org/10.1080/15284336.2016.1261073

Odermatt J., Friedli N., Kutz A., Briel M., Bucher H.C., Christ-Crain M., Burkhardt O., Welte T., Mueller B., & Schuetz P. (2017). Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis. Clinical Chemistry and Laboratory Medicine, 56, 170–177. https://doi.org/10.1515/cclm-2017-0252

Petersen, Maya, Logan, Roger, Abgrall, Sophie, Touloumi, Giota, Vourli, Georgia, Vandenhende, Marie-Anne, Reiss, Peter, van Sighem, Ard, Samji, Hasina, Rybniker, Jan, Jose, Sophie, Moreno, Santiago, Cozzi-Lepri, Alessandro, Stephan, Christoph, Jarrin, Inma, Antinori, Andrea, Moore, Richard, Casabona, Jordi, Meyer, Laurence, et al. (2016). Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 45, 2038–2049. https://doi.org/10.1093/ije/dyv295

Olson AD, Walker AS, Suthar AB, Sabin C, Bucher HC, Jarrin I, Moreno S, Perez-Hoyos S, Porter K, Ford D, & CASCADE Collaboration in EuroCoord. (2016). Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death. Journal of acquired immune deficiency syndromes (1999), 73(1), 100–108. https://doi.org/10.1097/qai.0000000000001029

Caniglia EC, Sabin C, Robins JM, Logan R, Cain LE, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RR, Reiss P, van Sighem A, Mathews WC, Del Amo J, et al. (2016). When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study. (Patent No. 2). 72(2), Article 2. https://doi.org/10.1097/qai.0000000000000956

Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, et al. (2016). Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials. PLoS medicine, 13(6), e1002046. https://doi.org/10.1371/journal.pmed.1002046

De Luca,Andrea, Flandre,Philippe, Dunn,David, Zazzi,Maurizio, Wensing,Annemarie, Santoro,Maria Mercedes, Günthard,Huldrych F, Wittkop,Linda, Kordossis,Theodoros, Garcia,Federico, Castagna,Antonella, Cozzi-Lepri,Alessandro, Churchill,Duncan, De Wit,Stéphane, Brockmeyer,Norbert H, Imaz,Arkaitz, Mussini,Cristina, Obel,Niels, Perno,Carlo Federico, et al. (2016). Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. The Journal of antimicrobial chemotherapy, 71(5), 1352–1360. https://doi.org/10.1093/jac/dkv465

Ademi Z, Gloy V, Glinz D, Raatz H, Van Stiphout J, Bucher HC, & Schwenkglenks M. (2016). Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective. Swiss medical weekly, 146, w14382. https://doi.org/10.4414/smw.2016.14382

Aouri,Manel, Barcelo,Catalina, Ternon,Béatrice, Cavassini,Matthias, Anagnostopoulos,Alexia, Yerly,Sabine, Hugues,Henry, Vernazza,Pietro, Günthard,Huldrych F, Buclin,Thierry, Telenti,Amalio, Rotger,Margalida, Decosterd,Laurent A, & Swiss HIV Cohort Study. (2016). In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid. Drug metabolism and disposition: the biological fate of chemicals, 44(1), 151–161. https://doi.org/10.1124/dmd.115.065839

Mocroft,Amanda, Lundgren,Jens D, Ross,Michael, Fux,Christoph A, Reiss,Peter, Moranne,Olivier, Morlat,Philippe, Monforte,Antonella d’Arminio, Kirk,Ole, Ryom,Lene, & Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. (2016). Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study. The Lancet HIV, 3(1), e23–e32. https://doi.org/10.1016/s2352-3018(15)00211-8

Schandelmaier S., Von Elm E., You J.J., Blumle A., Tomonaga Y., Lamontagne F., Saccilotto R., Amstutz A., Bengough T., Meerpohl J.J., Stegert M., Olu K.K., Tikkinen K.A.O., Neumann I., Carrasco-Labra A., Faulhaber M., Mulla S.M., Mertz D., Akl E.A., et al. (2016). Premature discontinuation of randomized trials in critical and emergency care: A retrospective cohort study. Critical Care Medicine, 44(1), 130–137. https://doi.org/10.1097/ccm.0000000000001369

Dell-Kuster S, Clavien PA, Bucher HC, & Rosenthal R. (2015). Classification of Intraoperative Complications: Reply. (Patent No. 12). 39(12), Article 12. https://doi.org/10.1007/s00268-015-3199-x

Young J, Moodie EE, Abrahamowicz M, Klein MB, Weber R, & Bucher HC. (2015). Incomplete Modeling of the Effect of Antiretroviral Therapy on the Risk of Cardiovascular Events. (Patent No. 7). 61(7), Article 7. https://doi.org/10.1093/cid/civ515

Young J., Rickenbach M, Calmy A., Bernasconi E., Staehelin C., Schmid P, Cavassini M, Battegay M, Gunthard H.F., Bucher HC, Aubert V., Battegay M., Bernasconi E., Boni J., Bucher H.C., Burton-Jeangros C., Calmy A., Cavassini M., Dollenmaier G., et al. (2015). Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study. BMC Infectious Diseases, 15(1). https://doi.org/10.1186/s12879-015-1120-8

Lodi S., Phillips A., Logan R., Olson A., Costagliola D., Abgrall S., van Sighem A., Reiss P., Miró J.M., Ferrer E., Justice A., Gandhi N., Bucher H.C., Furrer H., Moreno S., Monge S., Touloumi G., Pantazis N., Sterne J., et al. (2015). Comparative eff ectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: Observational cohort study. The Lancet HIV, 2(8), e335–e343. https://doi.org/10.1016/s2352-3018(15)00108-3

Rosenthal R., von Websky, M. W., Hoffmann H., Vitz, M., Hahnloser D., Bucher, H. C., & Schafer J. (2015). How to report multiple outcome metrics in virtual reality simulation. European Surgery - Acta Chirurgica Austriaca, 47(4), 202–205. https://doi.org/10.1007/s10353-015-0327-7

Young,Jim, Xiao,Yongling, Moodie,Erica E M, Abrahamowicz,Michal, Klein,Marina B, Bernasconi,Enos, Schmid,Patrick, Calmy,Alexandra, Cavassini,Matthias, Cusini,Alexia, Weber,Rainer, Bucher,Heiner C, Bucher,Heiner C, & Swiss HIV Cohort Study. (2015). Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999), 69(4), 413–421. https://doi.org/10.1097/qai.0000000000000662

Rosenthal R, Hoffmann H, Clavien PA, Bucher HC, & Dell-Kuster S. (2015). Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation. World journal of surgery, 39(7), 1663–1671. https://doi.org/10.1007/s00268-015-3003-y

Rohner A, Ried K, Sobenin IA, Bucher HC, & Nordmann AJ. (2015). A systematic review and metaanalysis on the effects of garlic preparations on blood pressure in individuals with hypertension. American journal of hypertension, 28(3), 414–423. https://doi.org/10.1093/ajh/hpu165

Gueler,Aysel, Schoeni-Affolter,Franziska, Moser,André, Bertisch,Barbara, Bucher,Heiner C, Bucher,Heiner C, Calmy,Alexandra, Cavassini,Matthias, Ledergerber,Bruno, Wandeler,Gilles, Egger,Matthias, & Swiss HIV Cohort Study Swiss National Cohort. (2015). Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland. AIDS (London, England), 29(2), 231–238. https://doi.org/10.1097/qad.0000000000000524

Rosenthal R, Hoffmann H, Dwan K, Clavien PA, & Bucher HC. (2015). Reporting of adverse events in surgical trials: critical appraisal of current practice. World journal of surgery, 39(1), 80–87. https://doi.org/10.1007/s00268-014-2776-8

Wandeler G, Schlauri M, Jaquier ME, Rohrbach J, Metzner KJ, Fehr J, Ambrosioni J, Cavassini M, Stöckle M, Schmid P, Bernasconi E, Keiser O, Salazar-Vizcaya L, Furrer H, Rauch A, Swiss HIV Cohort Study, Aubert V, Battegay M, Bernasconi E, et al. (2015). Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infectious Diseases, 2(1), ofv026. https://doi.org/10.1093/ofid/ofv026

Lodi S., Lodi S, Moreno S., Bucher H.C., Bucher HC, Logan R., Sterne J., Sterne J, Pérez-Hoyos S, Phillips A., Olson A., Olson A, Reiss P., Sabin C., Jose S., Justice A., Justice A, Miro J.M., Ferrer E., et al. (2014). Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries. Aids, 28(16), 2461–2473. https://doi.org/10.1097/qad.0000000000000456

Dell-Kuster S, Lauper S, Koehler J, Zwimpfer J, Altermatt B, Zwimpfer T, Zwimpfer L, Young J, Bucher HC, & Nordmann AJ. (2014). Assessing work ability--a cross-sectional study of interrater agreement between disability claimants, treating physicians, and medical experts. Scandinavian Journal of Work, Environment & Health, 40(5), 493–501. https://doi.org/10.5271/sjweh.3440

Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, Winston A, van Sighem A, Miro JM, Podzamczer D, Olson A, Arribas JR, Moreno S, Meyer L, del Romero J, Dabis F, Bucher HC, Wandeler G, Vourli G, et al. (2014). Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions. Neurology, 83(2), 134–141. https://doi.org/10.1212/wnl.0000000000000564

Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, et al. (2014). Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 58(9), 1312–1321. https://doi.org/10.1093/cid/ciu038

Fidler S, Olson A, Fox J, Phillips A, Morrison C, Thornhill J, Bucher H, Muga R, & Porter K. (2014). The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART. Journal of the International AIDS Society, 17(4 Suppl 3), 19820. https://doi.org/10.7448/ias.17.4.19820

Kanters, Steve, Nachega, Jean, Funk, Anna, Mukasa, Barbara, Montaner, Julio S. G., Ford, Nathan, Bucher, Heiner C., & Mills, Edward J. (2014). CD4(+) T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysis. ANTIVIRAL THERAPY, 19, 31–39. https://doi.org/10.3851/imp2670

Vale,Noah, Nordmann,Alain J, Schwartz,Gregory G, de Lemos,James, Colivicchi,Furio, den Hartog,Frank, Ostadal,Petr, Macin,Stella M, Liem,Anho H, Mills,Edward J, Bhatnagar,Neera, Bucher,Heiner C, & Briel,Matthias. (2014). Statins for acute coronary syndrome. Cochrane Database Syst Rev, 9(1), CD006870.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, & Briel M. (2013). Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Evidence-based child health : a Cochrane review journal, 8(4), 1297–1371. https://doi.org/10.1002/ebch.1927

Touloumi G, Pantazis N, Pillay D, Paraskevis D, Chaix ML, Bucher HC, Kücherer C, Zangerle R, Kran AM, Porter K, & CASCADE collaboration in EuroCoord. (2013). Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56(6), 888–897. https://doi.org/10.1093/cid/cis1000

Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, Nattermann J, Lampe FC, Bucher HC, Sterling TR, Crane HM, Kitahata MM, May M, & Sterne JA. (2013). An internationally generalizable risk index for mortality after one year of antiretroviral therapy. (Patent No. 4). 27(4), Article 4. https://doi.org/10.1097/qad.0b013e32835b8c7f

Kanters, S., Nachega, J., Funk, A., Mukasa, B., Montaner, J. S., Ford, N., Bucher, H. C., & Mills, E. J. (2013). CD4 T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysis. Antiviral Therapy, 19(1), 31–39. https://doi.org/10.3851/imp2670

Touloumi G, Pantazis N, Chaix ML, Bucher HC, Zangerle R, Kran AM, Thiebaut R, Masquelier B, Kucherer C, Monforte Ad, Meyer L, Porter K, & for CASCADE Collaboration in EuroCoord. (2013). Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration. PloS one, 8(7), e71174. https://doi.org/10.1371/journal.pone.0071174